In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs

Research output: Contribution to journalJournal articleResearchpeer-review

The GluN2C subunit exists predominantly, but not exclusively in NMDA receptors within the cerebellum. Antagonists such as UBP1700 and positive allosteric modulators including PYD-106 and 3-acylamino-2-aminopropionic acid derivatives such as UA3-10 ((R)-2-amino-3-{[5-(2-bromophenyl)thiophen-2-yl]carboxamido}propionic acid) represent promising tool compounds to investigate the role of GluN2C-containing NMDA receptors in the signal transduction in the brain. However, due to its high polarity the bioavailability and CNS penetration of the amino acid UA3-10 are expected to be rather low. Herein, three ester prodrugs 12a-c of the NMDA receptor glycine site agonist UA3-10 were prepared and pharmacokinetically characterized. The esters 12a-c showed higher lipophilicity (higher logD7.4 values) than the acid UA3-10 but almost the same binding at human serum albumin. The acid UA3-10 was rather stable upon incubation with mouse liver microsomes and NADPH, but the esters 12a-c were fast hydrolyzed to afford the acid UA3-10. Incubation with pig liver esterase and mouse serum led to rapid hydrolysis of the esters 12a-c. The isopropyl ester 12c showed a promising logD7.4 value of 3.57 and the highest stability in the presence of pig liver esterase and mouse serum. These results demonstrate that ester prodrugs of UA3-10 can potentially afford improved bioavailability and CNS penetration.

Original languageEnglish
JournalBiological Chemistry
Volume404
Issue number4
Pages (from-to)255-265
ISSN1431-6730
DOIs
Publication statusPublished - 2023

Bibliographical note

Funding Information:
Research funding: This work was supported by the Research Training Group “Chemical biology of ion channels (Chembion)” funded by the Deutsche Forschungsgemeinschaft (DFG) [GRK 2515/1], which is gratefully acknowledged. The authors acknowledge financial support from the National Institutes of Health [NS097536] to K.B.H.

Publisher Copyright:
© 2022 Walter de Gruyter GmbH, Berlin/Boston.

    Research areas

  • 3-acylamino-2-aminopropionic acid derivatives, GluN2C subtype-specific NMDA agonists, hydrolytic stability, in vitro ADME, physicochemical parameters, UA3-10

ID: 330836907